stockrow
Saturday 7 November 2026
Export NVNO’s income statement to Excel — free account
enVVeno Medical Corporation
NVNO Healthcare Medical Devices
- EPS
- +22.0%
- Free cash flow
- +27.6%
Quarter to September 2026, against a year earlier
6.39
0.58
−8.32%
Follow NVNO
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
7.13 | 11.39 | 11.63 | 13.30 | |
Current Ratio |
7.35 | 11.70 | 11.89 | 13.58 | |
Net Debt/EBITDA |
4.18 | 5.70 | 6.33 | 7.24 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.73 | 0.99 | 0.84 | 0.92 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(4.58) | (5.29) | (4.95) | (5.85) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(4.58) | (5.29) | (4.95) | (5.85) | |
Cash per Share |
26.62 | 32.02 | 38.12 | 47.90 | |
Shareholders Equity per Share |
24.35 | 30.80 | 36.31 | 46.06 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
24.35 | 30.80 | 36.31 | 46.06 | |
Free Cash Flow |
(3.18) | (3.55) | (3.24) | (3.44) | |
Working Capital |
16.43 | 20.20 | 23.35 | 26.70 | |
Capital Expenditures |
— | — | — | 0.00 | |
Net Current Asset Value |
16.43 | 20.09 | 23.14 | 26.39 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | — | 0.00 | |
| Other line items | |||||
Average Payables |
2.15 | 2.06 | 1.52 | 1.73 | |
Average Assets |
25.92 | 29.62 | 33.34 | 37.26 | |
Average Common Equity |
23.17 | 26.86 | 31.03 | 34.64 |
Columns are period end dates · fundamentals updated 2 Nov 2026